Company: ABBV
Filing Date: 2025-02-26
Form Type: 8-K
Source: 0001104659-25-017490
Chunk: 0

Company: AbbVie Inc.
Filing Date: 2025-02-26
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item 8.01.      Other Events.  

On February 26, 2025, AbbVie Inc. (“ AbbVie”)
completed its previously announced underwritten public offering (the “ Notes Offering”) of $1,250,000,000 billion in
aggregate principal amount of its 4.650% senior notes due 2028 (the “2028 Notes”), $1,000,000,000 in aggregate principal
amount of its 4.875% senior notes due 2030 (the “2030 Notes”), $1,000,000,000 in aggregate principal amount of its
5.200% senior notes due 2035 (the “2035 Notes”) and $750,000,000 in aggregate principal amount of its 5.600% senior
notes due 2055 (the “2055 Notes” and, together with the 2028 Notes, the 2030 Notes and the 2035 Notes, the “ Notes”).